Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
Oncology|November 7, 2012
Treatment strategy for superficial pharyngeal squamous cell carcinoma synchronously combined with esophageal cancerKazuhiro Kaneko, Tomonori Yano, Keiko Minashi, et al.
BMC Cancer|October 13, 2019
The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY)Hiroaki Tanioka, Takeshi Nagasaka, Futoshi Uno, et al.
Journal of Clinical Medicine|April 23, 2022
Real-World Data of Trastuzumab Deruxtecan for Advanced Gastric Cancer: A Multi-Institutional Retrospective StudyToshihiko Matsumoto, Shogo Yamamura, Tatsuki Ikoma, et al.
Cancer Chemotherapy and Pharmacology|October 24, 2020
Phase 1 study of Gemcitabine/Nab-paclitaxel/S-1 in patients with unresectable pancreatic cancer (GeNeS1S trial)Satoshi Sai, Masanori Toyoda, Kazutoshi Tobimatsu, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 9, 2024
Short-term outcomes of a phase II trial of perioperative capecitabine plus oxaliplatin therapy for advanced gastric cancer with extensive lymph node metastases (OGSG1701)Yutaka Kimura, Naotoshi Sugimoto, Shunji Endo, et al.
Japanese Journal of Clinical Oncology|September 22, 2022
Germline variants in cancer-predisposing genes in pancreatic cancer patients with a family history of cancerTakeshi Terashima, Chigusa Morizane, Mineko Ushiama, et al.
Investigational New Drugs|May 21, 2021
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first-line treatment for metastatic colorectal cancer: Safety lead-in results from the QUATTRO-II studyDaisuke Kotani, Takayuki Yoshino, Masahito Kotaka, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 11, 2021
Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction: KSCC1601Masaaki Iwatsuki, Hiroyuki Orita, Kazuma Kobayashi, et al.
International Journal of Clinical Oncology|February 20, 2019
Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safetyHiroaki Tanioka, Michitaka Honda, Chihiro Tanaka, et al.
ESMO Open|August 2, 2017
Phase I study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PI)Hironaga Satake, Akira Miki, Masato Kondo, et al.
Pageof 12